Murabito JM, D’Agostino RB, Silbershatz H, Wilson WF: Intermittent claudication: a risk profile from the Framingham Heart Study. .Circulation 96::44. –49,1997.

• PubMed
Murabito JM, D’Agostino RB, Silbershatz H, Wilson WF: Intermittent claudication: a risk profile from the Framingham Heart Study. .Circulation96::44. –49,1997. 9236415)| false
• Search Google Scholar
• Export Citation

Hiatt WR: Medical treatment of peripheral arterial disease and claudication. .N Engl J Med 344::1608. –1621,2001.

• PubMed
Hiatt WR: Medical treatment of peripheral arterial disease and claudication. .N Engl J Med344::1608. –1621,2001. 11372014)| false
• Search Google Scholar
• Export Citation

Criqui MH: Peripheral arterial disease: epidemiological aspects. .Vascular Medicine 6: (Suppl. 1):3. –7,2001.

Criqui MH: Peripheral arterial disease: epidemiological aspects. .Vascular Medicine6: (Suppl. 1):3. –7,2001. )| false
• Search Google Scholar
• Export Citation

Bernstein EF, Fronek A: Current status of noninvasive tests in the diagnosis of peripheral arterial disease. .Surg Clin North Am 62::473. –487,1982.

• PubMed
Bernstein EF, Fronek A: Current status of noninvasive tests in the diagnosis of peripheral arterial disease. .Surg Clin North Am62::473. –487,1982. 7089825)| false
• Search Google Scholar
• Export Citation

Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. .Practical Diabetes Int 16::163. –166,1999.

Elhadd TA, Robb R, Jung RT, Stonebridge PA, Belch JJF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. .Practical Diabetes Int16::163. –166,1999. )| false
• Search Google Scholar
• Export Citation

Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. .JAMA 286::1317. –1324,2001.

• PubMed
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. .JAMA286::1317. –1324,2001. 11560536)| false
• Search Google Scholar
• Export Citation

Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. .Circulation 94::3026. –3049,1996.

• PubMed
Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL, Strandness DE Jr, Taylor LM: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. .Circulation94::3026. –3049,1996. 8941154)| false
• Search Google Scholar
• Export Citation

Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Concensus (TASC). .J Vasc Surg 31::S1. –S296,2000.

• PubMed
Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Concensus (TASC). .J Vasc Surg31::S1. –S296,2000. 10666287)| false
• Search Google Scholar
• Export Citation

Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G, McDermott MM: Peripheral artery disease, diabetes, and reduced lower extremity functioning. .Diabetes Care 25::113. –120,2002.

• PubMed
Dolan NC, Liu K, Criqui MH, Greenland P, Guralnik JM, Chan C, Schneider JR, Mandapat AL, Martin G, McDermott MM: Peripheral artery disease, diabetes, and reduced lower extremity functioning. .Diabetes Care25::113. –120,2002. 11772911)| false
• Search Google Scholar
• Export Citation

McDaniel MD, Cronenwett JL: Basic data related to the natural history of intermittent claudication. .Ann Vasc Surg 3::273. –277,1989.

• PubMed
McDaniel MD, Cronenwett JL: Basic data related to the natural history of intermittent claudication. .Ann Vasc Surg3::273. –277,1989. 2673321)| false
• Search Google Scholar
• Export Citation

Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. .JAMA 287::2570. –2581,2002.

• PubMed
Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. .JAMA287::2570. –2581,2002. 12020339)| false
• Search Google Scholar
• Export Citation

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. .Circulation 97::425. –428,1998.

• PubMed
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. .Circulation97::425. –428,1998. 9490235)| false
• Search Google Scholar
• Export Citation

Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. .Diabetes 47::457. –463,1998.

• PubMed
Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. .Diabetes47::457. –463,1998. 9519754)| false
• Search Google Scholar
• Export Citation

Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. .Diabetologia 45::623. –634,2002.

• PubMed
Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. .Diabetologia45::623. –634,2002. 12107742)| false
• Search Google Scholar
• Export Citation

Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP: Nitric oxide regulates monocyte chemotactic protein-1. .Circulation 96::934. –940,1997.

• PubMed
Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP: Nitric oxide regulates monocyte chemotactic protein-1. .Circulation96::934. –940,1997. 9264504)| false
• Search Google Scholar
• Export Citation

Geng YJ, Libby P: Progression of atheroma: a struggle between death and procreation. .Arterioscler Thromb Vasc Biol 22::1370. –1380,2002.

• PubMed
Geng YJ, Libby P: Progression of atheroma: a struggle between death and procreation. .Arterioscler Thromb Vasc Biol22::1370. –1380,2002. 12231554)| false
• Search Google Scholar
• Export Citation

Schneider DL, Sobel BE: Diabetes and thrombosis. In Diabetes and Cardiovascular Disease. Johnstone MT, Veves A, Eds. Totowa, NJ, Humana Press. ,2001.

American Diabetes Association: Preventive foot care in people with diabetes (Position Statement). .Diabetes Care 26: (Suppl. 1):S78. –S79,2003.

• PubMed
American Diabetes Association: Preventive foot care in people with diabetes (Position Statement). .Diabetes Care26: (Suppl. 1):S78. –S79,2003. 12502623)| false
• Search Google Scholar
• Export Citation

Strandness DE Jr, Bell JW: Peripheral vascular disease: diagnosis and evaluation using a mercury strain gauge. .Ann Surg 161: (Suppl. 4):1. –35,1965.

• PubMed
Strandness DE Jr, Bell JW: Peripheral vascular disease: diagnosis and evaluation using a mercury strain gauge. .Ann Surg161: (Suppl. 4):1. –35,1965. 14252628)| false
• Search Google Scholar
• Export Citation

Lassila R, Lepantalo M: Cigarette smoking and the outcome after lower limb arterial surgery. .Acta Chir Scand 154::635. –640,1988.

• PubMed
Lassila R, Lepantalo M: Cigarette smoking and the outcome after lower limb arterial surgery. .Acta Chir Scand154::635. –640,1988. 3232481)| false
• Search Google Scholar
• Export Citation

UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). .Lancet 352::837. –853,1998.

• PubMed
UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). .Lancet352::837. –853,1998. 9742976)| false
• Search Google Scholar
• Export Citation

Stokes J, Kannel WB, Wolf PA, Cupples LA, D’Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. .Circulation 75::V65. –V73,1987.

• PubMed
Stokes J, Kannel WB, Wolf PA, Cupples LA, D’Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. .Circulation75::V65. –V73,1987. 3568338)| false
• Search Google Scholar
• Export Citation

UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). .BMJ 317::703. –713,1998.

• PubMed
UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). .BMJ317::703. –713,1998. 9732337)| false
• Search Google Scholar
• Export Citation

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. .N Engl J Med 342::145. –153,2000.

• PubMed
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. .N Engl J Med342::145. –153,2000. 10639539)| false
• Search Google Scholar
• Export Citation

Leng GC, Price JF, Jepson RG: Lipid-lowering for lower limb atherosclerosis (Cochrane Review). .Cochrane Database Syst Rev 2::CD000123. ,2000.

Leng GC, Price JF, Jepson RG: Lipid-lowering for lower limb atherosclerosis (Cochrane Review). .Cochrane Database Syst Rev2::CD000123. ,2000. )| false
• Search Google Scholar
• Export Citation

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). .Lancet 344::1383. –1389,1994.

• PubMed
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). .Lancet344::1383. –1389,1994. 7968073)| false
• Search Google Scholar
• Export Citation

Kjekshus J, Pedersen TR: Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). .Am J Cardiol 76::64C. –68C,1995.

• PubMed
Kjekshus J, Pedersen TR: Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). .Am J Cardiol76::64C. –68C,1995. 7572690)| false
• Search Google Scholar
• Export Citation

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. .Lancet 360::7. –22,2002.

• PubMed
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. .Lancet360::7. –22,2002. 12114036)| false
• Search Google Scholar
• Export Citation

Antiplatelet Trialists’ Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. .Br Med J 308::81. –106,1994.

Antiplatelet Trialists’ Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. .Br Med J308::81. –106,1994. )| false
• Search Google Scholar
• Export Citation

American Diabetes Association: Aspirin therapy in diabetes (Position Statement). .Diabetes Care 26: (Suppl. 1):S87. –S88,2003.

• PubMed
American Diabetes Association: Aspirin therapy in diabetes (Position Statement). .Diabetes Care26: (Suppl. 1):S87. –S88,2003. 12502626)| false
• Search Google Scholar
• Export Citation

CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). .Lancet 348::1329. –1339,1996.

• PubMed
CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). .Lancet348::1329. –1339,1996. 8918275)| false
• Search Google Scholar
• Export Citation

Larsen OA, Lassen NA: Effect of daily muscular exercise in patients with intermittent claudication. .Lancet 2::1093. –1096,1966.

• PubMed
Larsen OA, Lassen NA: Effect of daily muscular exercise in patients with intermittent claudication. .Lancet2::1093. –1096,1966. 4162526)| false
• Search Google Scholar
• Export Citation

Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication (Cochrane Review). .Cochrane Database Syst Rev 2::CD000990. ,2000.

Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication (Cochrane Review). .Cochrane Database Syst Rev2::CD000990. ,2000. )| false
• Search Google Scholar
• Export Citation

Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR: Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. .J Am Geriatr Soc 50::1939. –1946,2002.

• PubMed
Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR: Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. .J Am Geriatr Soc50::1939. –1946,2002. 12473004)| false
• Search Google Scholar
• Export Citation

Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd, Martin JD, Bortey EB, Forbes WP, Strandness DE: A comparison of cilostazol and pentoxifylline for treating intermittent claudication. .Am J Med 109::523. –530,2000.

• PubMed
Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd, Martin JD, Bortey EB, Forbes WP, Strandness DE: A comparison of cilostazol and pentoxifylline for treating intermittent claudication. .Am J Med109::523. –530,2000. 11063952)| false
• Search Google Scholar
• Export Citation

Kannel WB, Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. .J Cardiovasc Risk 1::3333. –3339,1994.

Kannel WB, Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. .J Cardiovasc Risk1::3333. –3339,1994. )| false
• Search Google Scholar
• Export Citation

American Diabetes Association: Diabetic foot wound care (Consensus Statement). .Diabetes Care 21::1354. –1360,1999.

American Diabetes Association: Diabetic foot wound care (Consensus Statement). .Diabetes Care21::1354. –1360,1999. )| false
• Search Google Scholar
• Export Citation